IC emergency balversa order
Ended Awarded Last action
- Contract number
- 36C26321N0602
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $24,522
Award facts
- Contract value 39% obligated
- $62,248.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$37,727 | |
| Supplemental Agreement for work within scope | -$37,727 | |
| Supplemental Agreement for work within scope | $9,432 | |
| Original award | $90,544 |
About this award
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The order, valued at $62,248.81, is for the cancer treatment drug BALVERSA to support healthcare services for veterans. The delivery order was issued under Janssen's General Services Administration Multiple Award Schedule Contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows the VA to efficiently procure needed medications. Janssen has provided BALVERSA and other oncology drugs to various VA medical facilities across the country through this contract vehicle, which has a completion date of September 30, 2021. There was no set-aside designation for this award.
Quick answers
Who was awarded contract 36C26321N0602?
36C26321N0602 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on April 6, 2021.
How much is contract 36C26321N0602 worth?
The government has obligated $24,522 on 36C26321N0602. Its current value, with exercised options, is $62,249.
Is contract 36C26321N0602 an order under another contract?
Yes. 36C26321N0602 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26321N0602 competed?
The extent of competition for 36C26321N0602 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award